CANDACE HARRIS: Open Payments
NPI 1518445139 · HOOVER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,679 in 101 payments from 14 companies in 2025. Trend: 2023 $343 · 2024 $110 · 2025 $1,679
Food & beverage: $1,679
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $454 |
| AstraZeneca Pharmaceuticals LP | 12 | $185 |
| GlaxoSmithKline, LLC. | 10 | $170 |
| Novo Nordisk Inc | 11 | $155 |
| Amgen Inc. | 9 | $152 |
| PFIZER INC. | 6 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $109 |
| SHIELD THERAPEUTICS INC | 4 | $85 |
| Exact Sciences Corporation | 5 | $76 |
| Lilly USA, LLC | 2 | $45 |
Products named: UBRELVY, TRELEGY ELLIPTA, AIRSUPRA, VRAYLAR, TRINTELLIX, QULIPTA, OTEZLA, ELIQUIS.
Industry payments across AL — which companies pay providers there.
